Mandate

VINGE ADVISES WILLIS IN ACQUISITION OF MAX MATTHIESSEN

June 13, 2014

Vinge assists global risk adviser, insurance and reinsurance broker Willis Group Holdings plc in connection with its acquisition of a controlling stake in Max Matthiessen. Willis acquires approximately 75 % of the Swedish employee benefits advisor for approximately SEK 1.357 billion from Altor Fund III (50 %) and employees (25 %). Approximately 25 % is retained by employees.
 
Willis is listed on NYSE and operates on every continent with more than 18,000 employees in over 400 offices. Willis Sweden has 140 employees in four offices and is headquartered in Stockholm.
 
Max Matthiessen operates in retirement savings, health plans and personal insurance. The company has around 420 employees in 23 locations across Sweden. Gross turnover in 2013 exceeded SEK 1 billion. The combined business of Willis and Max Matthiessen will create the biggest risk adviser and broker in the Nordic region.
 
The acquisition is conditional upon customary regulatory approvals and conditions to closing.
 
Vinge’s team consisted of among others responsible partner Carl Gustaf De Geer, partner Malin Ohlin, project manager Peter Sundgren and associates Filip Brosset and Sofie Bjärtun (M&A), as well as associates Axel Hedberg (financial regulatory), Nina Farrahi (compliance), Emil Fahlén Godö (competition law) and Evelina Tejle (employment law).

 

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026